ProShares Ultra Health Care (RXL)
| Assets | $62.39M |
| Expense Ratio | 0.95% |
| PE Ratio | 24.86 |
| Shares Out | 1.63M |
| Dividend (ttm) | $0.58 |
| Dividend Yield | 1.49% |
| Ex-Dividend Date | Mar 26, 2025 |
| Payout Ratio | 37.02% |
| 1-Year Return | -21.81% |
| Volume | 12,127 |
| Open | 39.00 |
| Previous Close | 39.12 |
| Day's Range | 38.92 - 39.00 |
| 52-Week Low | 36.52 |
| 52-Week High | 58.74 |
| Beta | 1.36 |
| Holdings | 72 |
| Inception Date | Jan 30, 2007 |
About RXL
Fund Home PageThe ProShares Ultra Health Care (RXL) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund provides 2x leveraged exposure to a cap-weighted index of US health care companies. RXL was launched on Jan 30, 2007 and is issued by ProShares.
Top 10 Holdings
69.49% of assets| Name | Symbol | Weight |
|---|---|---|
| United States Treasury Bills 0% | B.0 06.05.25 | 11.26% |
| Eli Lilly and Company | LLY | 9.67% |
| United States Treasury Bills 0% | B.0 05.27.25 | 9.66% |
| United States Treasury Bills 0% | B.0 06.24.25 | 9.63% |
| Johnson & Johnson | JNJ | 6.33% |
| AbbVie Inc. | ABBV | 5.56% |
| United States Treasury Bills 0% | B.0 06.17.25 | 4.82% |
| UnitedHealth Group Incorporated | UNH | 4.68% |
| Cte ? Proshares Trust M | n/a | 3.95% |
| Abbott Laboratories | ABT | 3.92% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 26, 2025 | $0.13435 | Apr 1, 2025 |
| Dec 23, 2024 | $0.14718 | Dec 31, 2024 |
| Sep 25, 2024 | $0.1285 | Oct 2, 2024 |
| Jun 26, 2024 | $0.1725 | Jul 3, 2024 |
| Mar 20, 2024 | $0.08603 | Mar 27, 2024 |
| Dec 20, 2023 | $0.08414 | Dec 28, 2023 |
News
ProShares Announces ETF Share Splits
BETHESDA, Md.--(BUSINESS WIRE)--ProShares announced forward and reverse share splits on 22 of its ETFs.
ProShares and ProFunds Announce Benchmark Changes for 53 Geared Sector Funds
BETHESDA, Md.--(BUSINESS WIRE)--ProShares and ProFunds, premier providers of leveraged and inverse funds, announced plans to change the underlying indices for a combined 53 sector ETFs and mutual fu...
Biotech Innovations Remain At Forefront
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...
Healthcare: A Wide Choice Of Large And Well-Established Companies
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...
RXL Is The Best Healthcare ETF Wealth-Builder Now
RXL Is The Best Healthcare ETF Wealth-Builder Now